CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Regulation FD disclosure
Page 4 of 8 · 159 filings